no image available Dickens & Co. "A Breakthrough in Breast Cancer Treatment: Unveiling ABI007's Promising Pharmacokinetic Profile" "A New Standard for Targeted Breast Cancer Therapy: ABI007's Phase I Study Shows Encouraging Results" Price: 29.00€